04.02.2013 10:00
Bewerten
(0)

GE Healthcare Works to Speed Up Fight Against Cancer

DRUCKEN

GE Healthcare’s work to accelerate cancer innovation and improve care for cancer patients reached new milestones in advanced technology.

The campaign is founded on GE Healthcare’s integrated portfolio, which is uniquely positioned to drive impact in oncology and a leap forward for individualized cancer care. GE Healthcare launched a series of new oncology technologies and systems to help advance cancer diagnostic and molecular imaging in 2012.

"At GE, we are committed to the ongoing fight against cancer, the leading cause of death worldwide,” said John Dineen, president and CEO, GE Healthcare. "I’m proud of the investment and innovations that we’ve made over the past year and look forward to working with our customers and partners to develop new technologies and oncology solutions. We fully support World Cancer Day on 4 February to highlight the determination of the international community to fight cancer.”

New Technologies to Help Improve Screening, Diagnosis, and Treatment

  • FlightPlan for Liver Cancer Liver cancer is the fifth most common cancer in men (523,000 cases p/y) and the seventh in women (226,000 cases p/y). To help physicians accurately identify vessels and block the blood supply to the tumor (liver embolization), a standard palliative treatment for liver cancer, GE Healthcare received U.S. FDA clearance in late 2012 for its advanced imaging tool, FlightPlan for Liver. With FlightPlan for Liver, available worldwide, physicians can gain confidence in identifying tumor-feeding vessels and be more selective when planning liver embolization.
  • MR-Guided Focused Ultrasound Therapy for Bone Pain Palliation In October 2012, the U.S. FDA approved Insightec’s ExAblate MRI-guided focused ultrasound for treatment of painful bone metastases in patients who are not candidates for or refuse to undergo radiation treatment. InSightec’s ExAblate system is exclusively compatible with GE Healthcare’s normal and wide bore systems. It combines therapeutic acoustic ultrasound waves with continuous guidance and treatment monitoring by MRI. This unique combination of technologies is called Magnetic Resonance guided Focused Ultrasound Therapy (MRgFUS). Physicians use MRI to plan and guide therapy and monitor treatment outcome. Focused ultrasound acoustic energy destroys nerves causing pain from bone metastases, resulting in rapid pain reduction. GE Healthcare is a minority shareholder of InSightec, Ltd., and is a distributor of ExAblate in many countries around the world.
  • GE Healthcare Acquires U-Systems, Inc GE Healthcare’s acquisition of a unique automated breast ultrasound imaging technology positions the company with a large portfolio of breast imaging solutions. The automated breast ultrasound system (ABUS) is a powerful tool that can help physicians find mammographically occult cancers hiding in dense breast tissue. According to published industry reports, over 40% of women in the U.S. with dense breast tissue are more likely to get breast cancer than those without dense breast tissue. Recent studies have demonstrated with the addition of ABUS that radiologists have found about 30 percent more cancers in women who have a normal mammogram, normal physical examination and dense breasts.
  • Increasing patient comfort for mammography screenings Healthcare is personal – particularly for women undergoing mammograms. Designed to divert a women’s attention away from the discomfort associated with mammography screenings, SensorySuite from GE Healthcare, now commercially available, provides a customized environment involving sight, smell and hearing during an examination. Around 25% of women avoid mammograms because of worry and fear. SensorySuite now provides a blend of interactive tools, selected decorative wall panels, with associated sounds and fragrances to distract the patient from a potentially stressful examination.
  • PET/CT in the fight against cancer GE Healthcare has launched new technologies in their ‘Q Suite’, enabling clinicians to minimize the impact and quickly address movement during a PET/CT scan, including thorax movement while the patient is breathing. These technologies help give clinicians diagnostic confidence while helping to minimize exposure to dose.

Continued Development of Omnyx Integrated Digital Pathology

With a combined $100M+ investment, Omnyx is a joint venture of GE Healthcare and University of Pittsburgh Medical Center (UPMC), formed out of a vision to bring pathology into the digital age and improve the research performance of pathology departments worldwide. By combining the technology innovation and backing of GE Healthcare with the pathology expertise and insight of UPMC, Omnyx is developing an Integrated Digital Pathology Solution. Designed to integrate the pathology department from image scanning and case preparation to case review, the Omnyx solution will digitize pathology and raise the performance standard for digital pathology research solutions. Omnyx Integrated Digital Pathology (IDP) is the result of extensive collaborations with more than 30 thought leading pathologists from 13 academic medical centers and research laboratories around the globe.

Omnyx® products are for research use only. Not for use in diagnostic procedures.

Cancer Awareness and Support through Social Media

GE Healthcare runs a number of successful global campaigns on social media that allow people from all over the world to share their story, show their support to those whose lives are affected by cancer and spread the word on the importance of early diagnosis. The Company has been recognized with external industry awards for its #GetFit campaign, a worldwide competition on multiple social media platforms to raise public awareness about cancer prevention. Find out more about #GetFit and other cancer awareness initiatives here.

-ends-

About GE Healthcare

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

For our latest news, please visit http://newsroom.gehealthcare.com

Nachrichten zu General Electric Co.

  • Relevant
    1
  • Alle
    2
  • vom Unternehmen
  • Peer Group
  • ?
Milliardenübernahme
ABB kauft GE Industrial Solutions für 2,6 Milliarden US-Dollar
Der schweizerische Technologiekonzern ABB stärkt seinen Elektrifizierungsbereich und kauft für 2,6 Milliarden US-Dollar die GE Industrial Solutions.
00:35 Uhr

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu General Electric Co.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
20.09.2017General Electric UnderweightJP Morgan Chase & Co.
19.09.2017General Electric UnderweightJP Morgan Chase & Co.
07.09.2017General Electric UnderweightJP Morgan Chase & Co.
25.07.2017General Electric BuyStifel, Nicolaus & Co., Inc.
25.07.2017General Electric buyUBS AG
25.07.2017General Electric BuyStifel, Nicolaus & Co., Inc.
25.07.2017General Electric buyUBS AG
24.04.2017General Electric OutperformRBC Capital Markets
24.02.2017General Electric (GE) kaufenBernstein Research
24.01.2017General Electric (GE) buyUBS AG
24.07.2017General Electric neutralMorgan Stanley
24.07.2017General Electric NeutralGoldman Sachs Group Inc.
17.07.2017General Electric Equal-WeightMorgan Stanley
07.07.2017General Electric NeutralGoldman Sachs Group Inc.
29.06.2017General Electric HoldStandpoint Research
20.09.2017General Electric UnderweightJP Morgan Chase & Co.
19.09.2017General Electric UnderweightJP Morgan Chase & Co.
07.09.2017General Electric UnderweightJP Morgan Chase & Co.
24.07.2017General Electric UnderweightJP Morgan Chase & Co.
08.06.2017General Electric SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für General Electric Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

The rise of Tiger and Dragon: Die besten Aktien aus China!

China ist das Bevölkerungsreichste Land der Erde. Mit einem zuletzt gemeldeten Wirtschaftswachstum von fast 7 % im 1. Halbjahr 2017 ist das Land auf bestem Wege, das eigene Wachstumsziel zu übertreffen. Erfahren Sie im neuen Anlegermagazin, bei welchen chinesischen Aktien vielversprechende Zukunftsaussichten bestehen und warum.
Anlegermagazin kostenlos erhalten

Heute im Fokus

Euro fällt unter 1,18 Dollar: DAX legt zu -- Nach Apple-Keynote: iPhone 6 so günstig wie nie -- Commerzbank: Jahresprognose mit niedrigem Gewinn steht --thyssenkrupp, Amazon, Tesla im Fokus

Analysten sehen Kupferglanz bei Aurubis eingetrübt. Nach der Wahl ist Zahltag: Der künftige Bundestag wird wohl deutlich teurer. Französische Regierung stimmt angeblich Zugfusion von Siemens und Alstom zu. Merck-Aktie legt deutlich zu: UBS-Empfehlung schiebt an.

Top-Rankings

KW 38: Analysten-Flops der Woche
Diese Aktien stehen auf den Verkauflisten der Experten
KW 38: Analysten-Tops der Woche
Diese Aktien stehen auf den Kauflisten der Experten
KW 37: Analysten-Flops der Woche
Diese Aktien stehen auf den Verkauflisten der Experten

Die 5 beliebtesten Top-Rankings

Der CEO von Allianz, BMW oder doch Daimler?
Diese Manager lieben die Deutschen
Das sind 2017 bislang die größten Verlierer in Buffetts Depot
Welche Aktie enttäuschte bisher am meisten?
Bizarre Steuereinnahmen
Das sind die bizarrsten Steuereinnahmen der Welt
Nicht nur schön und talentiert
Diese Frauen haben in Hollywood am meisten verdient
Diese Banken wurden für die Finanzkrise am härtesten bestraft
Welche Bank zahlte am meisten?
mehr Top Rankings

Umfrage

Angela Merkel kann zwar voraussichtlich vier weitere Jahre regieren - aber nur mit dem größten Verlust in der Geschichte ihrer Union. Hätten Sie sich einen neuen Kanzler gewünscht?

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Goldpreis
Meistgesucht
BYD Co. Ltd.A0M4W9
Daimler AG710000
Volkswagen (VW) AG Vz.766403
Deutsche Bank AG514000
Apple Inc.865985
CommerzbankCBK100
Bitcoin Group SEA1TNV9
Nordex AGA0D655
Deutsche Telekom AG555750
AlibabaA117ME
E.ON SEENAG99
Allianz840400
TeslaA1CX3T
BASFBASF11
EVOTEC AG566480